Peer-reviewed veterinary case report
Dendrobium huoshanense attenuates Parkinsonian neurodegeneration via dual antioxidant and anti-inflammatory pathways.
- Journal:
- Journal of ethnopharmacology
- Year:
- 2026
- Authors:
- Yan, Congjie et al.
- Affiliation:
- School of Pharmacy and Hubei Shizhen Laboratory · China
- Species:
- rodent
Abstract
ETHNOPHARMACOLOGICAL RELEVANCE: Dendrobium huoshanense (DH), a traditional Chinese medicinal herb, is traditionally used for its anti-inflammatory and antioxidant properties, suggesting potential against neurodegenerative diseases like Parkinson's disease (PD). AIM OF THE STUDY: This study investigated how growth years affect DH's chemical composition and neuroprotective activities against PD, focusing on anti-inflammatory and antioxidant mechanisms. METHODS: DH extracts from different growth years (N1-N4) were analyzed chemically. Their effects were evaluated in D-galactose-stimulated PC12 cells and LPS-activated BV-2 microglia. The most potent four-year-old DH was further tested in an MPTP-induced PD mouse model using behavioral tests, immunohistochemistry, and Western blotting. RESULTS: Four-year-old DH exhibited the highest content of active compounds and significantly alleviated motor deficits in PD mice. It reduced oxidative stress and neuroinflammation by suppressing the NF-κB/NLRP3 pathway and activating the HO-1/Nrf2 antioxidant pathway. CONCLUSION: DH exerts neuroprotective effects against PD through dual regulation of the HO-1/Nrf2 and NF-κB/NLRP3 pathways, with efficacy enhanced by longer growth periods. These findings support DH's potential as a therapeutic agent for PD.
Find similar cases for your pet
PetCaseFinder finds other peer-reviewed reports of pets with the same symptoms, plus a plain-English summary of what was tried across them.
Search related cases →Original publication: https://pubmed.ncbi.nlm.nih.gov/41456823/